Securities fraud class action lawsuits against life sciences companies climbed 56 percent last year to 25 lawsuits filed, compared with 16 cases in 2006, according to a new Dechert survey. The report noted that the largest and smallest companies are the most likely to be sued, with large companies increasingly likely to face such lawsuits. In prior surveys, Dechert observed that nearly half of the cases were against small public companies with a market capitalization of less than $250 million.
June 18, 2008 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Securities fraud class action lawsuits against life sciences companies climbed 56 percent last year to 25 lawsuits filed, compared with 16 cases in 2006, according to a new Dechert survey.
The June 2008 Dechert “Survey of Securities Fraud Class Actions Brought Against Life Sciences Companies” also noted that the largest and smallest companies are the most likely to be sued, with large companies increasingly likely to face such lawsuits.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
At NJM, a top-rated insurance company, we are seeking an Attorney on our Workers Compensation legal team with between 3 and 5 years of expe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
